Nathan Connell: Bleeding Risk Is Not Limited to Delivery
Nathan Connell, Clinical Chief of Hematology at Brigham and Women’s Faulkner Hospital, shared a post on Linkedln about a recent article published in Haemophilia Journal, co-authored by him and his colleagues, adding:
“Just published in Haemophilia Journal in conjunction with the World Federation of Hemophilia 2026 Congress in Kuala Lumpur, Malaysia: ‘Obstetric and Gynaecologic Considerations in Inherited Bleeding Disorders.’
Women and girls with inherited bleeding disorders have too often been under-recognized, under-diagnosed, and under-served.
This review highlights that bleeding risk is not limited to delivery.
It spans the reproductive lifespan, from heavy menstrual bleeding and iron deficiency, to fertility treatment, prenatal diagnosis, pregnancy planning, neuraxial anesthesia decisions, mode of delivery, and both primary and secondary postpartum hemorrhage.
A central message of the paper is that care must be proactive, multidisciplinary, and individualized.
For many patients, better outcomes depend on earlier recognition of bleeding symptoms, coordinated care across hematology, obstetrics, gynecology, anesthesia, and genetics, and thoughtful delivery planning well before labor.
The review also underscores how advances in preconception counseling, prenatal testing, and carrier evaluation are reshaping reproductive choice and risk assessment.
This is also a call to move beyond the historical framing of women only as ‘carriers’ and toward a model that recognizes their own bleeding phenotype, health risks, and need for lifelong care.
Grateful to my coauthors Joanna Davies, Rezan Abdul-Kadir, and Zane Kaplan for their partnership on this work.”
Title: Obstetric and Gynaecologic Considerations in Inherited Bleeding Disorders
Authors: Nathan T. Connell, Joanna Davies, Rezan Abdul-Kadir, Zane Kaplan

Other posts featuring Nathan Connell on Hemostasis Today.
-
Jun 24, 2026, 13:50Tijjani Balas: Why Early Detection of DVT Matters
-
Jun 24, 2026, 13:43Brandon Michael Henry: Interpreting Complement Activation After AAV Gene Therapy
-
Jun 24, 2026, 13:37Heba Youssef: Heparin-Induced Thrombocytopenia – The Prothrombotic Emergency You Cannot Miss
-
Jun 24, 2026, 13:32Jecko Thachil: Understanding the Clinical Spectrum of Vitamin B12
-
Jun 24, 2026, 13:32Namrata Singh: Beyond Low Platelets – Understanding What Triggers ITP
-
Jun 24, 2026, 09:29Advancing Women’s Health Through Collaboration with Jean Hailes for Women’s Health – Stroke Foundation
-
Jun 24, 2026, 09:18The Lasting Immunological Footprint of VITT – JTH
-
Jun 24, 2026, 09:09Umberto Pensato: Dedicated Funding Pathways for Stroke Research in Italy
-
Jun 24, 2026, 09:00Danny Gaskin: BBTS 2026 and the Evolving Role of Transfusion in Maternity Care